Replies to post #389088 on Elite Pharmaceuticals Inc (ELTP)

[jour_trader]

So what you are a saying is that in our current $2B market being at a dime, with a $5B market we will be at a quarter. Vyvanse wont be a $5B market when we enter. That market will soon be shrinking by the day and will shrink significantly further once all the generics hit after 180-day stay is completed.